Shortened Activated Partial Thromboplastin Time Is Associated With Acute Ischemic Stroke, Stroke Severity, and Neurological Worsening
Stability of prothrombin time and activated partial thromboplastin time tests under different storage conditions
Activated Partial Thromboplastin Time
In vitro sensitivity of different activated partial thromboplastin time reagents to mild clotting factor deficiencies
Anti–Factor Xa and Activated Partial Thromboplastin Time Measurements for Heparin Monitoring in Mechanical Circulatory Support
Determination of heparin levels in blood with activated partial thromboplastin time by a piezoelectric quartz crystal sensor
Lupus Anticoagulant Positivity in Pediatric Patients With Prolonged Activated Partial Thromboplastin Time: A Single-Center Experience and Review of Literature
Antifactor Xa Levels versus Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin
Antifactor Xa levels vs. activated partial thromboplastin time for monitoring unfractionated heparin. A pilot study
